Mainz Biomed (MYNZ) News Today → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free MYNZ Stock Alerts $0.87 +0.15 (+20.86%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 31 at 5:01 PM | globenewswire.comMainz Biomed Reports Results of 2024 Annual General MeetingMay 30 at 5:56 AM | americanbankingnews.comMainz Biomed (NASDAQ:MYNZ) Short Interest Down 25.5% in MayMay 28, 2024 | finanznachrichten.deEQS-News: Mainz BioMed N.V.: Mainz Biomed präsentiert neue gepoolte Daten seiner bisher größten Darmkrebs-Screening-Studie auf der ASCO 2024May 28, 2024 | globenewswire.comMainz Biomed to Present New Pooled Colorectal Cancer Screening Data, its Largest Study to Date, at ASCO 2024 Annual MeetingMay 28, 2024 | americanbankingnews.comMainz Biomed (NASDAQ:MYNZ) Shares Up 1.6%May 20, 2024 | globenewswire.comMainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for its Planned FDA TrialMay 7, 2024 | finanznachrichten.deEQS-News: Mainz BioMed N.V.: Mainz Biomed präsentiert Ergebnisse der Darmkrebsfrüherkennungsstudie eAArly DETECT auf der Digestive Disease Week 2024May 7, 2024 | globenewswire.comMainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C.April 30, 2024 | uk.news.yahoo.comStrictly Come Dancing's Shirley Ballas shares important cancer update to fansApril 25, 2024 | globenewswire.comMainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer DiagnosticApril 17, 2024 | msn.comMainz Biomed N.V. (MYNZ) Price Target Decreased by 9.09% to 5.10April 10, 2024 | finance.yahoo.comThe Pharmaceutical Industry Finds Itself At A Historical CrossroadsApril 9, 2024 | investorplace.comMYNZ Stock Earnings: Mainz Biomed Beats EPS, Misses Revenue for Q4 2023April 9, 2024 | markets.businessinsider.comEQS-News: Mainz Biomed Reports Full Year 2023 Financial ResultsApril 9, 2024 | globenewswire.comMainz Biomed Reports Full Year 2023 Financial ResultsApril 5, 2024 | seekingalpha.comMYNZ Mainz Biomed N.V.April 2, 2024 | benzinga.comPharma's Post-Pandemic Story To Unlock A Cancer-Free EraMarch 19, 2024 | markets.businessinsider.comEQS-News: Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer TreatmentMarch 19, 2024 | globenewswire.comMainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer TreatmentMarch 18, 2024 | markets.businessinsider.comEQS-News: Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic OptionsMarch 18, 2024 | globenewswire.comMainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic OptionsMarch 12, 2024 | finanznachrichten.deMainz BioMed NV: Mainz Biomed Presents ColoAlert at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening InnovationsMarch 12, 2024 | globenewswire.comMainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening InnovationsMarch 5, 2024 | globenewswire.comMainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer DiagnosticFebruary 27, 2024 | markets.businessinsider.comEQS-News: Mainz Biomed to Showcase at the Gynecology Conference in Stuttgart, Germany, Strengthening Connections within the Medical CommunityFebruary 27, 2024 | globenewswire.comMainz Biomed to Showcase at the Gynecology Conference in Stuttgart, Germany, Strengthening Connections within the Medical CommunityFebruary 22, 2024 | markets.businessinsider.comEQS-News: Mainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlert®February 22, 2024 | finanznachrichten.deMainz BioMed NV: Mainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlertFebruary 22, 2024 | finance.yahoo.comMainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlert®February 22, 2024 | globenewswire.comMainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlert®February 21, 2024 | finanznachrichten.deEQS-News: Mainz BioMed N.V.: Mainz Biomed geht strategische Partnerschaft mit TomaLab zur Ausweitung der Verfügbarkeit von ColoAlert® in Italien einFebruary 21, 2024 | finanznachrichten.deMainz BioMed NV: Mainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert in ItalyFebruary 21, 2024 | markets.businessinsider.comEQS-News: Mainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert® in ItalyFebruary 21, 2024 | finance.yahoo.comMainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert® in ItalyFebruary 21, 2024 | globenewswire.comMainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert® in ItalyFebruary 6, 2024 | finance.yahoo.comMainz Biomed Establishes Physician-Led Laboratory Expanding Service Offering for Privately Insured Patients in GermanyFebruary 1, 2024 | benzinga.com2 Million Cancer Diagnoses And 600,000 Cancer Deaths Expected In 2024 – Prevention Is Key To Treatment, And Mainz Biomed Is Leading The ChargeJanuary 11, 2024 | tmcnet.comMainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdansk Gastroenterology SymposiumJanuary 11, 2024 | finance.yahoo.comMainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology SymposiumJanuary 9, 2024 | benzinga.com2024 Marks a New Era Of Pharmaceutical InnovationJanuary 9, 2024 | markets.businessinsider.comEQS-News: Mainz Biomed Provides Year-End Corporate Review 2023January 9, 2024 | finance.yahoo.comMainz Biomed Provides Year-End Corporate Review 2023December 19, 2023 | finance.yahoo.comMainz Biomed and Bantleon Partner to Elevate Corporate Health with Second Phase of CRC Screening Program for EmployeesDecember 12, 2023 | morningstar.comMainz Biomed NV MYNZDecember 12, 2023 | finanznachrichten.deEQS-News: Mainz BioMed N.V.: Mainz Biomed präsentiert ColoAlert® auf zwei führenden Gastroenterologie-Konferenzen in PolenDecember 12, 2023 | markets.businessinsider.comEQS-News: Mainz Biomed Showcases ColoAlert® at Two Prominent Gastroenterology Conferences in PolandDecember 12, 2023 | finance.yahoo.comMainz Biomed Showcases ColoAlert® at Two Prominent Gastroenterology Conferences in PolandDecember 6, 2023 | finanznachrichten.deEQS-News: Mainz BioMed N.V.: Mainz Biomed meldet positive Topline-Ergebnisse der US-Studie eAArly DETECT mit neuartigen mRNA-BiomarkernDecember 6, 2023 | markets.businessinsider.comMainz Biomed B.V.: Buy Rating with High CRC Detection Success and AI IntegrationDecember 5, 2023 | finance.yahoo.comMainz Biomed Reports Positive Topline Results from U.S. eAArly DETECT Study Evaluating Novel mRNA Biomarkers Get Mainz Biomed News Delivered to You Automatically Sign up to receive the latest news and ratings for MYNZ and its competitors with MarketBeat's FREE daily newsletter. Email Address Are You Positioned For The New Energy Goldrush? (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy. Click here to get all the information about it. MYNZ Media Mentions By Week MYNZ Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MYNZ News Sentiment▼0.450.76▲Average Medical News Sentiment MYNZ News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MYNZ Articles This Week▼72▲MYNZ Articles Average Week Get Mainz Biomed News Delivered to You Automatically Sign up to receive the latest news and ratings for MYNZ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: LAVA Therapeutics News NLS Pharmaceutics News Pharvaris News Procaps Group News Qilian International Holding Group News NantHealth News Talis Biomedical News Lucid Diagnostics News Biodesix News Sera Prognostics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MYNZ) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsWho are Nvidia’s New Silent Partners?Weiss RatingsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaHow Biden has already won 2024Porter & CompanyThis unknown company solves the biggest issue with AIManward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mainz Biomed Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
